alagebrium has been researched along with n-phenacylthiazolium bromide in 1 studies
| Studies (alagebrium) | Trials (alagebrium) | Recent Studies (post-2010) (alagebrium) | Studies (n-phenacylthiazolium bromide) | Trials (n-phenacylthiazolium bromide) | Recent Studies (post-2010) (n-phenacylthiazolium bromide) |
|---|---|---|---|---|---|
| 83 | 10 | 31 | 25 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamagishi, S | 1 |
1 review(s) available for alagebrium and n-phenacylthiazolium bromide
| Article | Year |
|---|---|
Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders.
Topics: Aging; Animals; Cross-Linking Reagents; Diabetes Complications; Glycation End Products, Advanced; Humans; Thiazoles | 2012 |